tiprankstipranks
Trending News
More News >
Kringle Pharma, Inc. (JP:4884)
:4884
Japanese Market

Kringle Pharma, Inc. (4884) Ratios

Compare
0 Followers

Kringle Pharma, Inc. Ratios

JP:4884's free cash flow for Q3 2025 was ¥1.00. For the 2025 fiscal year, JP:4884's free cash flow was decreased by ¥ and operating cash flow was ¥-12.61. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
35.70- 21.50 12.52 19.70
Quick Ratio
31.41- 19.20 10.78 17.55
Cash Ratio
27.95- 18.05 10.22 16.93
Solvency Ratio
>-0.01- 0.09 -1.43 0.22
Operating Cash Flow Ratio
0.00- -5.16 -3.30 0.10
Short-Term Operating Cash Flow Coverage
0.00- 0.00 0.00 0.00
Net Current Asset Value
¥ 1.36B-¥ 2.11B¥ 2.02B¥ 2.79B
Leverage Ratios
Debt-to-Assets Ratio
0.00- 0.00 0.00 0.00
Debt-to-Equity Ratio
0.00- 0.00 0.00 0.00
Debt-to-Capital Ratio
0.00- 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.00- 0.00 0.00 0.00
Financial Leverage Ratio
1.52- 1.31 1.30 1.15
Debt Service Coverage Ratio
0.00- 0.00 0.00 0.00
Interest Coverage Ratio
0.00- 0.00 0.00 0.00
Debt to Market Cap
0.00- 0.00 0.00 0.00
Interest Debt Per Share
0.00- 0.00 0.00 0.00
Net Debt to EBITDA
1.67- 2.83 2.40 0.00
Profitability Margins
Gross Profit Margin
100.00%-100.00%100.00%77.44%
EBIT Margin
-1347.43%--1020.77%-1283.41%-108.76%
EBITDA Margin
-1348.11%--1021.87%-1283.41%0.00%
Operating Profit Margin
-1347.80%--1021.87%-1283.41%-108.76%
Pretax Profit Margin
-1348.16%--943.25%-1231.28%-84.31%
Net Profit Margin
-1349.55%--945.12%-1233.43%-84.69%
Continuous Operations Profit Margin
-1349.55%--945.12%-1233.43%-84.69%
Net Income Per EBT
100.10%-100.20%100.17%100.45%
EBT Per EBIT
100.03%-92.31%95.94%77.51%
Return on Assets (ROA)
-46.35%--27.44%-32.62%-10.34%
Return on Equity (ROE)
-55.80%--35.88%-42.25%-11.90%
Return on Capital Employed (ROCE)
-47.60%--31.11%-36.88%-13.99%
Return on Invested Capital (ROIC)
-47.65%--31.17%-36.95%-14.05%
Return on Tangible Assets
-46.35%--27.44%-32.62%-10.34%
Earnings Yield
-36.27%--13.96%-19.86%-15.19%
Efficiency Ratios
Receivables Turnover
1.46- 1.40 0.85 5.77
Payables Turnover
0.00- 0.00 0.00 0.00
Inventory Turnover
0.00- 0.00 0.00 0.25
Fixed Asset Turnover
0.00- 0.00 0.00 0.00
Asset Turnover
0.03- 0.03 0.03 0.12
Working Capital Turnover Ratio
0.04- 0.03 0.03 0.14
Cash Conversion Cycle
249.54- 261.07 431.41 1.51K
Days of Sales Outstanding
249.54- 261.07 431.41 63.29
Days of Inventory Outstanding
0.00- 0.00 0.00 1.44K
Days of Payables Outstanding
0.00- 0.00 0.00 0.00
Operating Cycle
249.54- 261.07 431.41 1.51K
Cash Flow Ratios
Operating Cash Flow Per Share
0.00- -103.32 -127.84 3.25
Free Cash Flow Per Share
0.00- -103.32 -127.84 3.25
CapEx Per Share
0.00- 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
0.00- 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00- 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
0.00- 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
0.00- 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
0.00- -8.26 -9.95 0.04
Free Cash Flow Yield
0.00%--12.20%-16.02%0.72%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-2.76- -7.17 -5.04 -6.59
Price-to-Sales (P/S) Ratio
37.21- 67.72 62.11 5.58
Price-to-Book (P/B) Ratio
1.94- 2.57 2.13 0.78
Price-to-Free Cash Flow (P/FCF) Ratio
0.00- -8.20 -6.24 138.34
Price-to-Operating Cash Flow Ratio
0.00- -8.20 -6.24 138.34
Price-to-Earnings Growth (PEG) Ratio
0.36- 0.28 -0.04 1.14
Price-to-Fair Value
1.94- 2.57 2.13 0.78
Enterprise Value Multiple
-1.09- -3.80 -2.44 0.00
Enterprise Value
1.06B- 3.11B 2.16B -571.25M
EV to EBITDA
-1.09- -3.80 -2.44 0.00
EV to Sales
14.67- 38.82 31.26 -1.46
EV to Free Cash Flow
0.00- -4.70 -3.14 -36.16
EV to Operating Cash Flow
0.00- -4.70 -3.14 -36.16
Tangible Book Value Per Share
203.10- 329.44 375.07 574.39
Shareholders’ Equity Per Share
203.10- 329.44 375.07 574.39
Tax and Other Ratios
Effective Tax Rate
>-0.01- >-0.01 >-0.01 >-0.01
Revenue Per Share
10.59- 12.51 12.85 80.69
Net Income Per Share
-142.91- -118.21 -158.46 -68.33
Tax Burden
1.00- 1.00 1.00 1.00
Interest Burden
1.00- 0.92 0.96 0.78
Research & Development to Revenue
8.88- 8.04 10.34 1.36
SG&A to Revenue
0.00- 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00- 0.00 0.00 0.00
Income Quality
0.00- 0.87 0.81 -0.05
Currency in JPY